{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:30:46Z","timestamp":1789140646524,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,4]]},"DOI":"10.7759\/cureus.17722","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T17:44:06Z","timestamp":1630950246000},"source":"Crossref","is-referenced-by-count":13,"title":["Frequency of Subclinical Hypothyroidism in Women With Polycystic Ovary Syndrome"],"prefix":"10.7759","author":[{"given":"Deepak","family":"Raj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FNU","family":"Pooja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Chhabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FNU","family":"Kalpana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Lohana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirshan","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajeeha","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidra","family":"Naz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simra","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dua","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls","volume":"3","author":"Witchel SF","year":"2019","unstructured":"Witchel SF, Oberfield SE, Pe\u00f1a AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc. 2019, 3:1545-73. 10.1210\/js.2019-00078","journal-title":"J Endocr Soc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale HF","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018, 14:270-84. 10.1038\/nrendo.2018.24","journal-title":"Nat Rev Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz R","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z, et al.. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016, 2:16057. 10.1038\/nrdp.2016.57","journal-title":"Nat Rev Dis Primers"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/09513590009167709","article-title":"Polycystic ovary syndrome: an endocrine and metabolic disease","volume":"14","author":"Scarpitta AM","year":"2000","unstructured":"Scarpitta AM, Sinagra D. Polycystic ovary syndrome: an endocrine and metabolic disease. Gynecol Endocrinol. 2000, 14:392-5. 10.3109\/09513590009167709","journal-title":"Gynecol Endocrinol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-014-0504-7","article-title":"Frequency of nodular goiter and autoimmune thyroid disease in patients with polycystic ovary syndrome","volume":"49","author":"Duran C","year":"2015","unstructured":"Duran C, Basaran M, Kutlu O, et al.. Frequency of nodular goiter and autoimmune thyroid disease in patients with polycystic ovary syndrome. Endocrine. 2015, 49:464-9. 10.1007\/s12020-014-0504-7","journal-title":"Endocrine"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00700","article-title":"Subclinical hypothyroidism in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"9","author":"Ding X","year":"2018","unstructured":"Ding X, Yang L, Wang J, et al.. Subclinical hypothyroidism in polycystic ovary syndrome: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2018, 9:700. 10.3389\/fendo.2018.00700","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-107439","article-title":"Subclinical hypothyroidism - laboratory finding or disease?. (Article in German)","volume":"141","author":"Voigtl\u00e4nder R","year":"2016","unstructured":"Voigtl\u00e4nder R, F\u00fchrer D. Subclinical hypothyroidism - laboratory finding or disease?. (Article in German). Dtsch Med Wochenschr. 2016, 141:1134-6. 10.1055\/s-0042-107439","journal-title":"Dtsch Med Wochenschr"},{"key":"ref8","article-title":"Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship?","volume":"12","author":"Enzevaei A","year":"2014","unstructured":"Enzevaei A, Salehpour S, Tohidi M, Saharkhiz N. Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship?. Iran J Reprod Med. 2014, 12:481-6.","journal-title":"Iran J Reprod Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.109714","article-title":"Thyroid disorders in polycystic ovarian syndrome subjects: a tertiary hospital based cross-sectional study from Eastern India","volume":"17","author":"Sinha U","year":"2013","unstructured":"Sinha U, Sinharay K, Saha S, Longkumer TA, Baul SN, Pal SK. Thyroid disorders in polycystic ovarian syndrome subjects: a tertiary hospital based cross-sectional study from Eastern India. Indian J Endocrinol Metab. 2013, 17:304-9. 10.4103\/2230-8210.109714","journal-title":"Indian J Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0358","article-title":"The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study","volume":"175","author":"Tagliaferri V","year":"2016","unstructured":"Tagliaferri V, Romualdi D, Guido M, et al.. The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study. Eur J Endocrinol. 2016, 175:433-41. 10.1530\/EJE-16-0358","journal-title":"Eur J Endocrinol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2017.6584","article-title":"Clinical, hormonal, and metabolic parameters in women with subclinical hypothyroidism and polycystic ovary syndrome: a cross-sectional study","volume":"27","author":"Bedaiwy MA","year":"2018","unstructured":"Bedaiwy MA, Abdel-Rahman MY, Tan J, et al.. Clinical, hormonal, and metabolic parameters in women with subclinical hypothyroidism and polycystic ovary syndrome: a cross-sectional study. J Womens Health (Larchmt). 2018, 27:659-64. 10.1089\/jwh.2017.6584","journal-title":"J Womens Health (Larchmt)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0047","article-title":"Mechanisms in endocrinology: autoimmune thyroid disease: old and new players","volume":"170","author":"Effraimidis G","year":"2014","unstructured":"Effraimidis G, Wiersinga WM. Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur J Endocrinol. 2014, 170:R241-52. 10.1530\/EJE-14-0047","journal-title":"Eur J Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2010.06.008","article-title":"Polycystic ovary syndrome and autoimmunity","volume":"21","author":"Petr\u00edkov\u00e1 J","year":"2010","unstructured":"Petr\u00edkov\u00e1 J, Laz\u00farov\u00e1 I, Yehuda S. Polycystic ovary syndrome and autoimmunity. Eur J Intern Med. 2010, 21:369-71. 10.1016\/j.ejim.2010.06.008","journal-title":"Eur J Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.1996.0178","article-title":"Cyclic plasma IL-6 levels during normal menstrual cycle","volume":"9","author":"Angstwurm MW","year":"1997","unstructured":"Angstwurm MW, G\u00e4rtner R, Ziegler-Heitbrock HW. Cyclic plasma IL-6 levels during normal menstrual cycle. Cytokine. 1997, 9:370-4. 10.1006\/cyto.1996.0178","journal-title":"Cytokine"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.anireprosci.2009.05.019","article-title":"Localization of thyrotropin receptor and thyroglobulin in the bovine corpus luteum","volume":"118","author":"Mutinati M","year":"2010","unstructured":"Mutinati M, Desantis S, Rizzo A, Zizza S, Ventriglia G, Pantaleo M, Sciorsci RL. Localization of thyrotropin receptor and thyroglobulin in the bovine corpus luteum. Anim Reprod Sci. 2010, 118:1-6. 10.1016\/j.anireprosci.2009.05.019","journal-title":"Anim Reprod Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0611","article-title":"Management of endocrine disease: The impact of subclinical hypothyroidism on anthropometric characteristics, lipid, glucose and hormonal profile of PCOS patients: a systematic review and meta-analysis","volume":"176","author":"Pergialiotis V","year":"2017","unstructured":"Pergialiotis V, Konstantopoulos P, Prodromidou A, Florou V, Papantoniou N, Perrea DN. Management of endocrine disease: The impact of subclinical hypothyroidism on anthropometric characteristics, lipid, glucose and hormonal profile of PCOS patients: a systematic review and meta-analysis. Eur J Endocrinol. 2017, 176:R159-66. 10.1530\/EJE-16-0611","journal-title":"Eur J Endocrinol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000485619","article-title":"Subclinical hypothyroidism impact on the characteristics of patients with polycystic ovary syndrome. A meta-analysis of observational studies","volume":"83","author":"de Medeiros SF","year":"2018","unstructured":"de Medeiros SF, de Medeiros MA, Ormond CM, Barbosa JS, Yamamoto MM. Subclinical hypothyroidism impact on the characteristics of patients with polycystic ovary syndrome. A meta-analysis of observational studies. Gynecol Obstet Invest. 2018, 83:105-15. 10.1159\/000485619","journal-title":"Gynecol Obstet Invest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede H","year":"2010","unstructured":"Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010, 8:41. 10.1186\/1741-7015-8-41","journal-title":"BMC Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/NMD.0000000000000168","article-title":"Depressive symptoms and major depressive disorder in patients affected by subclinical hypothyroidism: a cross-sectional study","volume":"202","author":"Demartini B","year":"2014","unstructured":"Demartini B, Ranieri R, Masu A, Selle V, Scarone S, Gambini O. Depressive symptoms and major depressive disorder in patients affected by subclinical hypothyroidism: a cross-sectional study. J Nerv Ment Dis. 2014, 202:603-7. 10.1097\/NMD.0000000000000168","journal-title":"J Nerv Ment Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0418","article-title":"Subclinical hypothyroidism in pregnancy: a systematic review and meta-analysis","volume":"26","author":"Maraka S","year":"2016","unstructured":"Maraka S, Ospina NM, O'Keeffe DT, et al.. Subclinical hypothyroidism in pregnancy: a systematic review and meta-analysis. Thyroid. 2016, 26:580-90. 10.1089\/thy.2015.0418","journal-title":"Thyroid"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003053.pub5","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","author":"Tang T","year":"2012","unstructured":"Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2012, CD003053. 10.1002\/14651858.CD003053.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dms052","article-title":"Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies: systematic review and meta-analysis of RCTs","volume":"19","author":"Velkeniers B","year":"2013","unstructured":"Velkeniers B, Van Meerhaeghe A, Poppe K, Unuane D, Tournaye H, Haentjens P. Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies: systematic review and meta-analysis of RCTs. Hum Reprod Update. 2013, 19:251-8. 10.1093\/humupd\/dms052","journal-title":"Hum Reprod Update"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/66745-frequency-of-subclinical-hypothyroidism-in-women-with-polycystic-ovary-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:41Z","timestamp":1707507041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/66745-frequency-of-subclinical-hypothyroidism-in-women-with-polycystic-ovary-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,4]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.17722","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,4]]}}}